Promega and Watchmaker Genomics Announce Strategic Partnership
Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase
Advertisement
Promega Corporation has entered a strategic partnership with Watchmaker genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA Analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular applications.
"Watchmaker’s enzyme offers a combination of attributes that establish a new benchmark for reverse transcriptase performance," says Sara Mann, VP of Commercial Excellence at Promega. "By incorporating it into our portfolio, we are giving customers a powerful tool for improved accuracy and enhanced sensitivity of RNA-based assays."
This partnership marks the beginning of an expanded collaboration between Watchmaker Genomics and Promega, with both companies committed to developing next-generation enzyme technologies that address the evolving needs of molecular diagnostics and life science research.
Engineered for Clinical and Research Precision
Developed with Watchmaker’s proprietary protein engineering platform, the reverse transcriptase reflects the same precision design principles that underpin Watchmaker’s next-generation sequencing (NGS) reagent portfolio and delivers performance advantages that set it apart in advancing molecular analysis applications.
"This enzyme will meaningfully improve the accuracy and reliability of RNA analysis in diagnostic and research labs," said Brian Kudlow, Chief Scientific Officer of Watchmaker Genomics. "This collaboration showcases the power of our enzyme engineering platform to deliver specialized genomics solutions."
Other news from the department business & finance
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
Last viewed contents
Analytica USA celebrated its premiere on the US market - Key topics: digitalization and sustainability in the laboratory
Determining our biological age with sensor technology - Sweat provides information about longevity and resilience
Fair Rules for Sharing Sequence Data: New roadmap in Nature Microbiology - Combining openness and fairness in the data-intensive life sciences
How DNA can be decoded more easily - New Software Simplifies Analysis of “Jumping Genes”
Shining some light on the obscure proteome - Chemoproteomics draw the target landscape of HDAC drugs
Unchartered territory in the human genome
Comparison of two nano rulers - Study compares two methods for distance measurement in motile proteins
Imaging the dynamic cellular zoo made easier - This work will expand the ability to simultaneously monitor many processes in cells
How artificial intelligence can improve protein detection - Using AI to move the boundaries of microscopy
Novel AI-based software enables quick and reliable imaging of proteins in cells - Researchers programmed a tool that accurately recognises and picks proteins in electron cryo-tomography, substituting troublesome hand selection
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
